Table 1. Clinical trials currently underway in USA sorted by disease name and stem cell type investigated.
Disease Cell type being investigated
Acute myocardial infarction Autologous bone marrow-derived mesenchymal stem cells
Alzheimer’s disease Adult neuronal progenitor stem cell
Corneal degeneration Amniotic epithelial stem cells
Dental pulp necrosis Stem cells from human exfoliated deciduous teeth
Diabetes (type 1) Umbilical cord mesenchymal stem cells, hematopoietic stem cell
Heart failure Human cardiac stem cells, mesenchymal stem cells, adipose derived stem cells
Kidney failure Hematopoietic stem cell, autologous and allogeneic bone marrow stem cell, peripheral blood stem cell, mesenchymal stem cells
Macular degeneration (Age-related) Autologous bone marrow stem cells, adipose derived stem cells
Multiple sclerosis Adult neuronal progenitor stem cell, autologous mesenchymal stem cells, enriched hematopoietic stem cells, human umbilical cord mesenchymal stem cells, autologous adipose-derived mesenchymal stem cells, peripheral blood stem cell transplantation
Parkinson’s disease Adult neuronal progenitor stem cell, autologous bone marrow derived stem cells, adipose-derived stem cells
Rheumatoid arthritis Umbilical cord-derived mesenchymal stem cells, hematopoietic stem cell, bone marrow mesenchymal stem cell, peripheral blood stem cell
Source: U.S. National Institutes of Health, 2014.